Tuesday, August 29, 2006

FDA Panels: Rubber Stamps for New Drugs

At least that is what one watchdog group says. Eleven randomly selected FDA advisory committees suggested approval in 79 percent of votes on applications between 1998 and 2005, according to the study by National Research Center for Women & Families. The committees considered 89 products during that period.

Several Congressmen have ripped the FDA for failing to keep up with drug safety. Other groups have said the FDA has appointed doctors and scientists to advisory committees who have financial or or cozy relationships with companies whose products are directly considered.

See here for more.